InMed Pharmaceuticals (INM) Gross Profit (2021 - 2025)
InMed Pharmaceuticals' (INM) quarterly Gross Profit came in at $184194.0 in Q4 2025, down 60.04% year-on-year from $460894.0 in Q4 2024, and down 54.31% quarter-over-quarter from $403159.0 in Q3 2025.
InMed Pharmaceuticals (INM) Gross Profit (2021 - 2025) Analysis & Trends
InMed Pharmaceuticals' Gross Profit history runs 5 years deep, the most recent figure standing at $184194.0 for Q4 2025.
- On a quarterly basis, Gross Profit fell 60.04% year-over-year to $184194.0 in Q4 2025; TTM through Dec 2025 was $1.3 million, a 21.65% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, up 55.02% from the prior year.
- Gross Profit declined to $184194.0 in Q4 2025 per INM's latest filing, from $403159.0 in the prior quarter.
- Across five years, Gross Profit topped out at $1.6 million in Q2 2023 and bottomed at -$491018.0 in Q3 2022.
- The 5-year median for Gross Profit is $249714.0 (2022), against an average of $314202.0.
- Biggest YoY gain for Gross Profit was 2222.82% in 2024; the steepest drop was 70.32% in 2024.
- Year by year, Gross Profit stood at $111555.0 in 2021, then increased by 17.58% to $131163.0 in 2022, then surged by 147.13% to $324142.0 in 2023, then soared by 42.19% to $460894.0 in 2024, then plunged by 60.04% to $184194.0 in 2025.
- Per Business Quant, the three latest INM Gross Profit figures stand at $184194.0 (Q4 2025), $403159.0 (Q3 2025), and $576654.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 184,194.00 |
| Dec 31, 2025 | 184,194.00 |
| Sep 30, 2025 | 403,159.00 |
| Sep 30, 2025 | 403,159.00 |
| Jun 30, 2025 | 576,654.00 |
| Jun 30, 2025 | 576,654.00 |
| Mar 31, 2025 | 175,625.00 |
| Mar 31, 2025 | 175,625.00 |
| Dec 31, 2024 | 460,894.00 |
| Dec 31, 2024 | 460,894.00 |
| Sep 30, 2024 | 493,413.00 |
| Sep 30, 2024 | 493,413.00 |
| Jun 30, 2024 | 466,071.00 |
| Jun 30, 2024 | 466,071.00 |
| Mar 31, 2024 | 289,458.00 |
| Mar 31, 2024 | 289,458.00 |
| Dec 31, 2023 | 324,142.00 |
| Dec 31, 2023 | 324,142.00 |
| Sep 30, 2023 | 21,242.00 |
| Sep 30, 2023 | 21,242.00 |